Revaprazan structure
|
Common Name | Revaprazan | ||
|---|---|---|---|---|
| CAS Number | 199463-33-7 | Molecular Weight | 362.44300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H23FN4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RevaprazanRevaprazan (SB 641257) is a reversible proton pump inhibitor with significant anti-inflammatory effects. Revaprazan can be used for chronic gastric inflammation research[1][2]. |
| Name | N-(4-fluorophenyl)-4,5-dimethyl-6-[(1S)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]pyrimidin-2-amine |
|---|---|
| Synonym | More Synonyms |
| Description | Revaprazan (SB 641257) is a reversible proton pump inhibitor with significant anti-inflammatory effects. Revaprazan can be used for chronic gastric inflammation research[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H23FN4 |
|---|---|
| Molecular Weight | 362.44300 |
| Exact Mass | 362.19100 |
| PSA | 41.05000 |
| LogP | 5.23780 |
| InChIKey | LECZXZOBEZITCL-UHFFFAOYSA-N |
| SMILES | Cc1nc(Nc2ccc(F)cc2)nc(N2CCc3ccccc3C2C)c1C |
| Revaprazan [INN] |